Evidence map›Paper›PMID 35211301›Full record

ArticleClinical kidney journal2022

Podocytopathy in patients with monoclonal gammopathy: three patients and literature review.

Andrés Ribas, Adrián Puche, Javier Gimeno, Laia Sans, Clara Barrios, Eva Márquez, Dolores Naranjo, Belén Lloveras, Joan Lop, Natàlia Ramos and 4 more

Open access · goldAbstract read
In one paragraph

Article in Clinical kidney journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Podocytopathies.Nature reviews. Disease primers · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Andrés RibasNephrology Department, Hospital del Mar, Barcelona, Spain.
Adrián PuchePathology Department, Hospital del Mar, Barcelona, Spain.
Javier GimenoPathology Department, Hospital del Mar, Barcelona, Spain.
Laia SansNephrology Department, Hospital del Mar, Barcelona, Spain.
Clara BarriosNephrology Department, Hospital del Mar, Barcelona, Spain.
Eva MárquezNephrology Department, Hospital del Mar, Barcelona, Spain.
Dolores NaranjoPathology Department, Hospital del Mar, Barcelona, Spain.
Belén LloverasPathology Department, Hospital del Mar, Barcelona, Spain.
Joan LopPathology Department, Hospital del Mar, Barcelona, Spain.
Natàlia RamosNephrology Department, Hospital Vall d'Hebrón, Barcelona, Spain.
Maria José SolerNephrology Department, Hospital Vall d'Hebrón, Barcelona, Spain.
Alejandra GabaldonPathology Department, Hospital Vall d'Hebrón, Barcelona, Spain.
Marta CrespoNephrology Department, Hospital del Mar, Barcelona, Spain.
Eva RodríguezNephrology Department, Hospital del Mar, Barcelona, Spain.
Hospital Del Mar · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal manifestations of monoclonal gammopathies are of increasing interest among nephrologists. Typical manifestations include light chain cast nephropathy, amyloidosis or renal damage mediated by monoclonal immunoglobulin deposition. Podocytopathies in the setting of an underlying monoclonal gammopathy constitute a rare manifestation of these diseases and, although being described in the literature, remain a challenge since most data derive from case reports.

methodsA retrospective review of the clinical data of Hospital del Mar and Hospital Vall d'Hebron was performed to identify patients with minimal change disease (MCD) or focal and segmental glomerulosclerosis (FSGS) in the setting of neoplasms that produce monoclonal (M) protein. Additionally, a literature review on this topic was performed. This study aims to describe the clinical characteristics and outcomes of these patients.

resultsThree patients were identified to have podocytopathy and monoclonal gammopathy between the years 2013 and 2020. All three were males and  >65 years of age. Two patients were diagnosed with MCD and one patient was diagnosed with FSGS. All patients underwent a kidney biopsy and light and electron microscopic studies were performed. The underlying causes of monoclonal gammopathy were multiple myeloma in two cases and Waldeström macroglobulinemia in one case. Two patients developed nephrotic syndrome during the follow-up. All patients were under active hematological treatment. One patient presented a complete remission of proteinuria whereas the other two presented a partial remission.

conclusionsPodocytopathies may infrequently be found in patients with monoclonal gammopathies. Patients with overt glomerular proteinuria and hematological disorders with M protein should undergo a kidney biopsy for prompt diagnosis and to specify a prognosis. In addition, further study on this matter must be done to understand the pathophysiology and treat these patients appropriately.

Indexed as

focal segmental glomerulosclerosisMGRSminimal change diseasemultiple myelomapodocytopathyWäldestrom disease

Identifiers

PMID35211301
PMCPMC8862048
OpenAlexW3202718426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.